Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 1.31
-1.5 %
$ 20.3 M
Market Cap
-1.44
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
353.70%
EBIT
Estimate
128.82%
Net Income
Estimate
33.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
bioAffinity Technologies, Inc.
BIAF has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BIAF
EBIT FORECAST
EBIT Forecast Chart BIAF
NET INCOME FORECAST
Net Income Chart BIAF